Novavax to Participate in Jefferies London Healthcare Conference

Group 1 - Novavax, Inc. will participate in the Jefferies London Healthcare Conference on November 20, 2024, featuring a fireside chat with CEO John C. Jacobs and other management team members [1][2] - The fireside chat is scheduled from 11:00 to 11:25 a.m. Greenwich Mean Time and will be moderated by Roger Song, MD, CFA, an Equity Analyst [2] - A replay of the fireside chat will be available on Novavax's Events & Presentations page for 30 days following the conference [2] Group 2 - Novavax is a global company based in Gaithersburg, Maryland, focused on developing innovative vaccines to combat serious infectious diseases [3] - The company utilizes a differentiated vaccine platform that includes a recombinant protein approach, innovative nanoparticle technology, and the patented Matrix-M adjuvant to enhance immune response [3] - Novavax's portfolio includes a COVID-19 vaccine and candidates for COVID-19-Influenza Combination and stand-alone influenza vaccines, as well as involvement in the R21/Matrix-M malaria vaccine developed by the University of Oxford and Serum Institute of India [3]